Wall Street analysts forecast that National Health Investors Inc (NYSE:NHI) will report $1.40 earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have made estimates for National Health Investors’ earnings, with the highest EPS estimate coming in at $1.40 and the lowest estimate coming in at $1.39. National Health Investors reported earnings per share of $1.36 in the same quarter last year, which would suggest a positive year over year growth rate of 2.9%. The firm is expected to report its next quarterly earnings results before the market opens on Tuesday, February 19th.

According to Zacks, analysts expect that National Health Investors will report full-year earnings of $5.51 per share for the current year, with EPS estimates ranging from $5.51 to $5.52. For the next financial year, analysts expect that the business will post earnings of $5.60 per share, with EPS estimates ranging from $5.50 to $5.74. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover National Health Investors.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, February 19th. The real estate investment trust reported $1.35 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.04). The firm had revenue of $74.00 million for the quarter, compared to analyst estimates of $75.16 million. National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.35 EPS.

A number of research analysts recently issued reports on NHI shares. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, November 9th. Cantor Fitzgerald restated a “hold” rating and set a $80.00 price objective on shares of National Health Investors in a report on Thursday, November 8th. ValuEngine upgraded shares of National Health Investors from a “hold” rating to a “buy” rating in a report on Tuesday, December 11th. Finally, KeyCorp set a $65.00 price objective on shares of National Health Investors and gave the company a “sell” rating in a report on Thursday, December 20th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. National Health Investors presently has an average rating of “Hold” and a consensus target price of $75.38.

NYSE NHI traded down $2.77 during trading on Friday, reaching $81.80. 6,273 shares of the stock traded hands, compared to its average volume of 175,938. The stock has a market cap of $3.57 billion, a P/E ratio of 15.36 and a beta of 0.51. The company has a debt-to-equity ratio of 0.89, a quick ratio of 14.53 and a current ratio of 14.53. National Health Investors has a fifty-two week low of $64.00 and a fifty-two week high of $84.57.

The business also recently declared a quarterly dividend, which was paid on Thursday, January 31st. Shareholders of record on Monday, December 31st were paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 4.89%. The ex-dividend date of this dividend was Friday, December 28th. National Health Investors’s payout ratio is currently 75.05%.

In other National Health Investors news, insider Kristin Sallee Gaines sold 10,708 shares of National Health Investors stock in a transaction that occurred on Thursday, December 13th. The shares were sold at an average price of $80.36, for a total value of $860,494.88. Following the transaction, the insider now owns 43,644 shares of the company’s stock, valued at $3,507,231.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert A. Mccabe, Jr. sold 1,250 shares of National Health Investors stock in a transaction that occurred on Monday, November 26th. The shares were sold at an average price of $75.41, for a total transaction of $94,262.50. Following the completion of the transaction, the director now directly owns 13,120 shares in the company, valued at approximately $989,379.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 14,028 shares of company stock worth $1,119,529. Insiders own 5.63% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Eii Capital Management Inc. lifted its position in shares of National Health Investors by 3.1% in the fourth quarter. Eii Capital Management Inc. now owns 6,674 shares of the real estate investment trust’s stock worth $504,000 after purchasing an additional 200 shares in the last quarter. Pinnacle Financial Partners Inc. lifted its position in shares of National Health Investors by 1.2% in the fourth quarter. Pinnacle Financial Partners Inc. now owns 20,670 shares of the real estate investment trust’s stock worth $1,561,000 after purchasing an additional 250 shares in the last quarter. HL Financial Services LLC lifted its position in shares of National Health Investors by 2.1% in the fourth quarter. HL Financial Services LLC now owns 11,958 shares of the real estate investment trust’s stock worth $903,000 after purchasing an additional 250 shares in the last quarter. State of Alaska Department of Revenue lifted its position in shares of National Health Investors by 1.9% in the fourth quarter. State of Alaska Department of Revenue now owns 13,344 shares of the real estate investment trust’s stock worth $1,007,000 after purchasing an additional 255 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in shares of National Health Investors by 3.7% in the fourth quarter. Hsbc Holdings PLC now owns 7,475 shares of the real estate investment trust’s stock worth $564,000 after purchasing an additional 266 shares in the last quarter. 69.65% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Strangles

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.